Literature DB >> 16425085

Clinical significance of focal adhesion kinase in resectable pancreatic cancer.

Kenichiro Furuyama1, Ryuichiro Doi, Tomohiko Mori, Eiji Toyoda, Daisuke Ito, Kazuhiro Kami, Masayuki Koizumi, Atsushi Kida, Yoshiya Kawaguchi, Koji Fujimoto.   

Abstract

Focal adhesion kinase (FAK) is a non-receptor, cytoplasmic protein tyrosine kinase that is involved in the regulation of cellular signaling, migration, apoptosis, and cell cycle progression. Previous reports have shown that FAK is expressed in various kinds of cancer tissues and cancer cell lines; however, no information is available about human pancreatic carcinoma specimens. Tissue such specimens were obtained from 50 patients who underwent pancreatic resection for pancreatic invasive ductal carcinoma at our institute from 1996 to 2002. Immunohistochemical analysis of FAK was performed in the resected specimens. Focal adhesion kinase expression in seven human pancreatic cancer cell lines was analyzed by reverse transcription polymerase chain reaction (PCR) analysis and Western blot analysis. Focal adhesion kinase expression was detected in 24 of 50 cases (48%). There was a statistically significant correlation between FAK expression and tumor size (P=0.004), although FAK expression did not significantly correlate with other factors such as tumor histological grade, lymph node metastasis, distant metastasis, histological stage, and overall survival. Reverse transcription PCR analysis and Western blot analysis showed that FAK was expressed in all seven pancreatic cancer cell lines. Focal adhesion kinase expression was not directly related to clinicopathological factors except tumor size in pancreatic carcinoma. Focal adhesion kinase expression may not be a prognostic marker for pancreatic cancer patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16425085     DOI: 10.1007/s00268-005-0165-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  27 in total

1.  Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas.

Authors:  K W Millikan; D J Deziel; J C Silverstein; T M Kanjo; J D Christein; A Doolas; R A Prinz
Journal:  Am Surg       Date:  1999-07       Impact factor: 0.688

2.  Focal adhesion kinase as a marker of invasive potential in differentiated human thyroid cancer.

Authors:  L V Owens; L Xu; G A Dent; X Yang; G C Sturge; R J Craven; W G Cance
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

3.  Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase.

Authors:  H C Chen; J L Guan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

4.  Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells.

Authors:  M Agochiya; V G Brunton; D W Owens; E K Parkinson; C Paraskeva; W N Keith; M C Frame
Journal:  Oncogene       Date:  1999-10-07       Impact factor: 9.867

5.  Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma.

Authors:  Shinji Itoh; Takashi Maeda; Mitsuo Shimada; Shin-ichi Aishima; Ken Shirabe; Shinji Tanaka; Yoshihiko Maehara
Journal:  Clin Cancer Res       Date:  2004-04-15       Impact factor: 12.531

6.  Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src.

Authors:  M D Schaller; J D Hildebrand; J D Shannon; J W Fox; R R Vines; J T Parsons
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

7.  Cell adhesion or integrin clustering increases phosphorylation of a focal adhesion-associated tyrosine kinase.

Authors:  L Kornberg; H S Earp; J T Parsons; M Schaller; R L Juliano
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

8.  Focal adhesion kinase expression in oral cancers.

Authors:  L J Kornberg
Journal:  Head Neck       Date:  1998-10       Impact factor: 3.147

9.  RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity.

Authors:  Mark S Duxbury; Hiromichi Ito; Eric Benoit; Michael J Zinner; Stanley W Ashley; Edward E Whang
Journal:  Biochem Biophys Res Commun       Date:  2003-11-21       Impact factor: 3.575

10.  p125 focal adhesion kinase promotes malignant astrocytoma cell proliferation in vivo.

Authors:  D Wang; J R Grammer; C S Cobbs; J E Stewart; Z Liu; R Rhoden; T P Hecker; Q Ding; C L Gladson
Journal:  J Cell Sci       Date:  2000-12       Impact factor: 5.285

View more
  35 in total

Review 1.  Pancreatic cancer: molecular pathogenesis and new therapeutic targets.

Authors:  Han H Wong; Nicholas R Lemoine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-06-09       Impact factor: 46.802

2.  Proteomic analysis of formalin-fixed paraffin-embedded pancreatic tissue using liquid chromatography tandem mass spectrometry.

Authors:  Joao A Paulo; Linda S Lee; Peter A Banks; Hanno Steen; Darwin L Conwell
Journal:  Pancreas       Date:  2012-03       Impact factor: 3.327

3.  Targeting the C-terminal focal adhesion kinase scaffold in pancreatic cancer.

Authors:  Priyanka N Gogate; Elena V Kurenova; Manivannan Ethirajan; Jianqun Liao; Michael Yemma; Arindam Sen; Ravindra K Pandey; William G Cance
Journal:  Cancer Lett       Date:  2014-07-24       Impact factor: 8.679

4.  Expression of focal adhesion kinase in small-cell lung carcinoma.

Authors:  Sebahat Ocak; Heidi Chen; Clay Callison; Adriana L Gonzalez; Pierre P Massion
Journal:  Cancer       Date:  2011-07-28       Impact factor: 6.860

Review 5.  Targeting focal adhesion kinase in neuroblastoma.

Authors:  Lauren Gillory; Elizabeth A Beierle
Journal:  Anticancer Agents Med Chem       Date:  2010-12       Impact factor: 2.505

6.  Expression and clinical significance of focal adhesion kinase in the two distinct histological types, intestinal and diffuse, of human gastric adenocarcinoma.

Authors:  Constantinos T Giaginis; Stephanie Vgenopoulou; Gerasimos S Tsourouflis; Ekaterini N Politi; Gregorios P Kouraklis; Stamatios E Theocharis
Journal:  Pathol Oncol Res       Date:  2008-11-06       Impact factor: 3.201

7.  Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines.

Authors:  Wu Huanwen; Liang Zhiyong; Shi Xiaohua; Ren Xinyu; Wang Kai; Liu Tonghua
Journal:  Mol Cancer       Date:  2009-12-21       Impact factor: 27.401

8.  Apigenin inhibits NNK-induced focal adhesion kinase activation in pancreatic cancer cells.

Authors:  Hung Pham; Monica Chen; Hiroki Takahashi; Jonathan King; Howard A Reber; Oscar Joe Hines; Stephen Pandol; Guido Eibl
Journal:  Pancreas       Date:  2012-11       Impact factor: 3.327

Review 9.  Biomarkers for predicting future metastasis of human gastrointestinal tumors.

Authors:  Lui Ng; Ronnie Tung Ping Poon; Roberta Pang
Journal:  Cell Mol Life Sci       Date:  2013-01-31       Impact factor: 9.261

10.  Biglycan expression and clinical outcome in patients with pancreatic adenocarcinoma.

Authors:  Giuseppe Aprile; Claudio Avellini; Michele Reni; Micol Mazzer; Luisa Foltran; Diego Rossi; Stefano Cereda; Emiliana Iaiza; Gianpiero Fasola; Andrea Piga
Journal:  Tumour Biol       Date:  2012-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.